ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 27, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will participate in the following investor conferences in February:

• Jones Research Precision Medicine Day – Participating in a fireside chat on Monday, February 3, 2025, at 12:30 p.m. ET
  
  
• Guggenheim Securities SMID Cap Biotech Conference – Participating in a fireside chat on Wednesday, February 5, 2025, at 1:30 p.m. ET
  
  
• Oppenheimer 35th Annual Healthcare Life Sciences Conference – Participating in a fireside chat on Tuesday, February 11, 2025, at 12:00 p.m. ET
  

Live webcasts of the discussions will be available through the investor section of the company’s website at www.oricpharma.com. Replays of the webcasts will be available for 90 days following the event.

About ORIC Pharmaceuticals, Inc.
ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer. ORIC’s clinical stage product candidates include (1) ORIC-114, a brain penetrant inhibitor that selectively targets EGFR exon 20, HER2 exon 20 and EGFR atypical mutations, being developed across multiple genetically defined cancers, and (2) ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer. Beyond these two product candidates, ORIC^® is also developing multiple precision medicines targeting other hallmark cancer resistance mechanisms. ORIC has offices in South San Francisco and San Diego, California. For more information, please go to www.oricpharma.com, and follow us on X or LinkedIn.

Contact:
Dominic Piscitelli, Chief Financial Officer
[email protected]
[email protected]

You May Also Be Interested In

• SkyBlue Cinematix Opens Its European Gateway in Germany — Appoints Sofia Torres Martinez to Lead 10 Markets Across Northern & Western Europe
• Keep Your Cool When the Vibes Heat Up: Desperados and Paolina Russo Drop the Ultimate Festival Jacket Powered by Frozen Beer
• EHang to Report Second Quarter 2026 Unaudited Financial Results on Tuesday, August 25, 2026